New evidence reveals adult human hearts can regrow muscle cells after myocardial infarction, opening new possibilities for ...
After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...
In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.
Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.
The Pioneer on MSN
Concept Medical enrols first patients in STARS DAPT trial
India, Jan. 25 -- Concept Medical Inc, a global developer of drug-delivery technologies for cardiovascular interventions, has ...
The Cool Down on MSN
Researchers issue warning after discovering overlooked factor that can increase heart attack risk: 'These findings raise concerns'
"They should not be assumed to be risk-free." Researchers issue warning after discovering overlooked factor that can increase ...
News-Medical.Net on MSN
TGM2 as a novel biomarker for acute myocardial infarction and prognosis in acute coronary syndrome
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has been implicated in various health conditions, yet its role in acute coronary ...
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...
Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality worldwide, primarily resulting from an abrupt coronary artery occlusion that deprives myocardial tissue of oxygen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results